Streptococcus pneumoniae type 1 capsular polysaccharide antigen Completed Phase 4 Trials for Chronic Plaque Psoriasis Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00493324Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis